Abbas Osma Ahmed, Ibrahim Issa Ghada, Ismail Abdel-Gawad Eman
Radioisotopes Department, Egyptian Atomic Energy Authority, Cairo, Egypt.
Iran J Pharm Res. 2019 Summer;18(3):1309-1322. doi: 10.22037/ijpr.2019.1100760.
With the advance in nanomedicine, the present study was conducted to explore the possible therapeutic role of intravenous nano- hydroxyapatite (nano-HAp) in male rats after chronic exposure to aluminum chloride (AlCl). This exposure interposed DNA fragmentation, apoptosis, alters oxidant/antioxidant status as well as change in content of neurotransmitters. The rats were injected with 100 mg/kg. body weight (b.w.) of AlCl intraperitoneally for 90 days, after then nano-HAp was injected intravenously (i.v.) three times per week at a dose level 100 mg/kg b.w. Based on the results obtained, it can be concluded that the treatment with the prepared nano-HAp restrains the damage inflicted on brain modulation by lipid oxidation products and decreased the susceptibility of apoptotic cells death with subsequent repaired the fragmented DNA as well as improved the synthesis of neurotransmitters. The most salient finding of nano-HAp treatment is the disappearance of most pathological changes due to AlCl administration.
随着纳米医学的发展,本研究旨在探讨静脉注射纳米羟基磷灰石(nano-HAp)对慢性暴露于氯化铝(AlCl)的雄性大鼠可能的治疗作用。这种暴露会导致DNA片段化、细胞凋亡,改变氧化/抗氧化状态以及神经递质含量的变化。大鼠腹腔注射100mg/kg体重的AlCl,持续90天,之后每周静脉注射(i.v.)三次纳米羟基磷灰石,剂量为100mg/kg体重。根据所得结果,可以得出结论:制备的纳米羟基磷灰石治疗可抑制脂质氧化产物对脑调节造成的损伤,降低凋亡细胞死亡的易感性,随后修复断裂的DNA,并改善神经递质的合成。纳米羟基磷灰石治疗最显著的发现是因给予AlCl而出现的大多数病理变化消失。